ADAP : Insider Transactions for Adaptimmune Therapeutics PLC

Company Profile Adaptimmune Therapeutics is a biopharmaceutical company focused on developing T-cell therapies for solid tumors. Co.'s proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables it to identify cancer targets, find and genetically engineer T-cell receptors against those targets, and produce therapeutic candidates (SPEAR T-cells) for administration to patients. Co. has clinical trials on its ADP-A2M4, ADP-A2M4CD8, each targeting the MAGE-A4 antigen, and ADP-A2AFP SPEAR T-cells targeting the alpha fetoprotein (AFP) cancer antigen in solid tumor types including non-small cell lung cancer, head and neck cancer, ovarian, urothelial, melanoma, and hepatocellular.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	39,000
Total Buy Value	$0	$0	$0	$11,326
Total People Bought	0	0	0	1
Total Buy Transactions	0	0	0	1
Total Shares Sold	0	165,799	218,930	354,372
Total Sell Value	$0	$124,385	$172,782	$411,912
Total People Sold	0	4	5	6
Total Sell Transactions	0	16	19	41
End Date	2024-02-04	2023-11-03	2023-05-05	2022-05-05

Adjust Filter Settings

Records found: 234

Page 6 of 10

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Orbimed Capital Gp V Llc

Director

– • –

2018-06-06

$13.49

$21,584

I/I

(1,600)

4,901,310

Thompson Peter A

Director

– • –

2018-06-06

$13.49

$21,584

I/I

(1,600)

4,901,310

Orbimed Capital Gp V Llc

Director

– • –

2018-06-04

$13.57

$232,047

I/I

(17,100)

4,902,910

Thompson Peter A

Director

– • –

2018-06-04

$13.57

$232,047

I/I

(17,100)

4,902,910

Orbimed Capital Gp V Llc

Director

– • –

2018-06-01

$13.49

$674,500

I/I

(50,000)

4,920,010

Thompson Peter A

Director

– • –

2018-06-01

$13.49

$674,500

I/I

(50,000)

4,920,010

Orbimed Capital Gp V Llc

Director

– • –

2018-05-30

$13.52

$1,635,920

I/I

(121,000)

4,970,010

Thompson Peter A

Director

– • –

2018-05-30

$13.52

$1,635,920

I/I

(121,000)

4,970,010

Orbimed Capital Gp V Llc

Director

– • –

2018-05-14

$13.50

$139,050

I/I

(10,300)

5,091,010

Thompson Peter A

Director

– • –

2018-05-14

$13.50

$139,050

I/I

(10,300)

5,091,010

Thompson Peter A

Director

– • –

2018-03-29

$11.53

$368,764

I/I

(31,983)

5,101,310

Orbimed Capital Gp V Llc

Director

– • –

2018-03-29

$11.53

$368,764

I/I

(31,983)

5,101,310

Thompson Peter A

Director

– • –

2018-03-27

$11.50

$11,684,966

I/I

(1,016,084)

5,133,293

Orbimed Capital Gp V Llc

Director

– • –

2018-03-27

$11.50

$11,684,966

I/I

(1,016,084)

5,133,293

Baskett Forest

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

1.5

Florence Anthony A. Jr.

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

1.5

Viswanathan Ravi

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

1.5

Kerins Patrick J

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

1.5

Barris Peter J

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

1.5

Nea 14 Gp, Ltd

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

D/D

6,000,000

79,978,672

2.45

Mott David M

Director

– • •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

2.25

Sandell Scott D

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

1.5

Sonsini Peter W.

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

1.5

Barrett M James

10% Owner

– – •

2018-03-27

$1.92

$11,500,200

I/I

6,000,000

79,978,672

1.5

Baskett Forest

10% Owner

– – •

2018-03-26

$1.90

$1,087,553

I/I

571,164

73,978,672

1.5

234 Records found	1 2 3 4 5 6 7 8 9 Next	Page 6 of 10

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: